Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-003044-20Phase 2Completed
Phase 2, randomised, double-blind trial of eucalyptol in acute bronchitis and nasopharyngitis (4 arms), sponsored by Cassella-med. Primary endpoint: Primary efficacy endpoint. Started Aug 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-003044-20.